SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-009950
Filing Date
2022-05-16
Accepted
2022-05-16 08:00:51
Documents
62
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q grtx-20220331.htm   iXBRL 10-Q 1485858
2 EX-31.1 grtx-ex31_1.htm EX-31.1 18497
3 EX-31.2 grtx-ex31_2.htm EX-31.2 21353
4 EX-32.1 grtx-ex32_1.htm EX-32.1 10338
5 EX-32.2 grtx-ex32_2.htm EX-32.2 9142
  Complete submission text file 0000950170-22-009950.txt   5717258

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT grtx-20220331.xsd EX-101.SCH 38721
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT grtx-20220331_pre.xml EX-101.PRE 223946
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT grtx-20220331_def.xml EX-101.DEF 96211
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT grtx-20220331_cal.xml EX-101.CAL 37215
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT grtx-20220331_lab.xml EX-101.LAB 333966
56 EXTRACTED XBRL INSTANCE DOCUMENT grtx-20220331_htm.xml XML 1031408
Mailing Address 2 WEST LIBERTY BLVD #100 MALVERN PA 19355
Business Address 2 WEST LIBERTY BLVD #100 MALVERN PA 19355 610-725-1500
Galera Therapeutics, Inc. (Filer) CIK: 0001563577 (see all company filings)

IRS No.: 461454898 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39114 | Film No.: 22925587
SIC: 2834 Pharmaceutical Preparations